PM

Paul A. Marks

SR Sloan Kettering Institute For Cancer Research: 23 patents #6 of 644Top 1%
CU Columbia University: 14 patents #70 of 2,492Top 3%
MC Memorial Sloan Kettering Cancer Center: 1 patents #402 of 761Top 55%
Google: 1 patents #14,769 of 22,993Top 65%
🗺 Connecticut: #1,318 of 34,797 inventorsTop 4%
Overall (All Time): #145,921 of 4,157,543Top 4%
27
Patents All Time

Issued Patents All Time

Showing 1–25 of 27 patents

Patent #TitleCo-InventorsDate
10626100 Selective HDAC6 inhibitors Ronald Breslow, Adaickapillai Mahendran, Yuanshan Yao 2020-04-21
9890136 Selective HDAC6 inhibitors Ronald Breslow, Adaickapillai Mahendran, Yuanshan Yao 2018-02-13
9539272 HDAC 6 inhibitor-based methods for treating cancer Weisheng Xu, Mandana Namdar 2017-01-10
9499479 Molecules that selectively inhibit histone deacetylase 6 relative to histone deacetylase 1 Ronald Breslow 2016-11-22
8327330 System and method of generating build instructions Don Hsi-Yun Yang 2012-12-04
7879865 Treatment of cancer of the brain using histone deacetylase inhibitors Victoria M. Richon, Richard A. Rifkind 2011-02-01
7816499 Antibodies that selectively bind HDAC9 Victoria M. Richon, Xianbo Zhou, Richard A. Rifkind 2010-10-19
7799803 Hydroxamic acid compounds and methods of use thereof Ronald Breslow, Thomas A. Miller, Sandro Belvedere, Victoria M. Richon, Richard A. Rifkind 2010-09-21
7345174 Cytodifferentiating agents and histone deacetylase inhibitors, and methods of use thereof Ronald Breslow, Sandro Belvedere, Leland Gershell, Thomas A. Miller, Victoria M. Richon +1 more 2008-03-18
7244604 HDAC9 polypeptides and polynucleotides and uses thereof Victoria M. Richon, Xianbo Zhou, Richard A. Rifkind 2007-07-17
7199134 Hydroxamic acid compounds and methods of use thereof Ronald Breslow, Thomas A. Miller, Sandro Belvedere, Victoria M. Richon, Richard A. Rifkind 2007-04-03
7126001 Class of cytodifferentiating agents and histone deacetylase inhibitors, and methods of use thereof Ronald Breslow, Sandro Belvedere, Leland Gershell, Thomas A. Miller, Victoria M. Richon +1 more 2006-10-24
7124068 Crystal structure of a deacetylase and inhibitors thereof Nikola Pavletich, Michael Finnin, Jill Donigian, Victoria M. Richon, Richard A. Rifkind +1 more 2006-10-17
7063973 HDAC9 polypeptides and polynucleotides and uses thereof Victoria M. Richon, Xianbo Zhou, Richard A. Rifkind 2006-06-20
RE38506 Potent inducers of terminal differentiation and methods of use thereof Ronald Breslow, Richard A. Rifkind, Branko Jursic 2004-04-20
6511990 Class of cytodifferentiating agents and histone deacetylase inhibitors, and methods of use thereof Ronald Breslow, Sandro Belvedere, Leland Gershell, Thomas A. Miller, Victoria M. Richon +1 more 2003-01-28
6087367 Potent inducers of terminal differentiation and methods of use thereof Ronald Breslow, Richard A. Rifkind, Branko Jursic 2000-07-11
5932616 Potent inducers of terminal differentiation and methods of use thereof Ronald Breslow, Richard A. Rifkind, Branko Jursic 1999-08-03
5840960 Potent inducers of terminal differentiation and method of use thereof Richard A. Rifkind, Ronald Breslow, Branko Jursic 1998-11-24
5773474 Potent inducers of terminal differentiation and method of use thereof Ronald Breslow, Richard A. Rifkind 1998-06-30
5700811 Potent inducers of terminal differentiation and method of use thereof Ronald Breslow, Richard A. Rifkind 1997-12-23
5668179 Potent inducers of terminal differentiation and method of use thereof Ronald Breslow, Richard A. Rifkind 1997-09-16
5608108 Potent inducers of terminal differentiation and method of use thereof Richard A. Rifkind, Ronald Breslow, Branko Jursic 1997-03-04
5369108 Potent inducers of terminal differentiation and methods of use thereof Ronald Breslow, Richard A. Rifkind, Branko Jursic 1994-11-29
5330744 Method for increasing sensitivity to chemically induced terminal differentiation Sandro Pontremoli, Ronald Breslow, Richard A. Rifkind 1994-07-19